Cargando…
Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
Receptor tyrosine kinases have been shown to dysregulate a number of pathways associated with tumor development, progression, and metastasis. Axl is a receptor tyrosine kinase expressed in many cancer types and has been associated with therapy resistance and poor clinical prognosis and outcomes. In...
Autores principales: | Tanaka, Mai, Siemann, Dietmar W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408754/ https://www.ncbi.nlm.nih.gov/pubmed/32660000 http://dx.doi.org/10.3390/cancers12071850 |
Ejemplares similares
-
Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer
por: Tanaka, Mai, et al.
Publicado: (2021) -
Axl signaling is an important mediator of tumor angiogenesis
por: Tanaka, Mai, et al.
Publicado: (2019) -
Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling
por: Tanaka, Mai, et al.
Publicado: (2021) -
Testosterone ameliorates vascular aging via the Gas6/Axl signaling pathway
por: Chen, Yan-Qing, et al.
Publicado: (2020) -
Gas6/AXL pathway: immunological landscape and therapeutic potential
por: Zhai, Xiaoqian, et al.
Publicado: (2023)